Crossmark

The impact of prostate volume estimation on the risk‐adapted biopsy decision based on prostate-specific antigen density and magnetic resonance imaging score

Crossref DOI link: https://doi.org/10.1007/s00345-024-04962-x

Published Online: 2024-05-15

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Baudewyns, Arthur

Guenzel, Karsten

Halinski, Adam

Dariane, Charles

Delavar, Gina

Anract, Julien

Barry Delongchamps, Nicolas

Jabbour, Teddy

Bourgeno, Henri-Alexandre

Lefebvre, Yolène

Ferriero, Mariaconsiglia

Simone, Giuseppe

Fourcade, Alexandre

Fournier, Georges

Oderda, Marco

Gontero, Paolo

Bernal-Gomez, Adrian

Mastrorosa, Alessandro

Roche, Jean-Baptiste

Zahr, Rawad Abou

Ploussard, Guillaume

Fiard, Gaelle

Rysankova, Katerina

Bui, Alexandre Patrick

Taha, Fayek

Windisch, Olivier

Benamran, Daniel

Vlahopoulos, Léonidas

Assenmacher, Gregoire

Roumeguère, Thierry

Peltier, Alexandre

Diamand, Romain https://orcid.org/0000-0002-2016-8543
License Information

Text and Data Mining valid from 2024-05-15

Version of Record valid from 2024-05-15
More Information

Article History

Received: 20 November 2023

Accepted: 25 March 2024

First Online: 15 May 2024

Declarations

:

: The authors declare that they have no conflict of interest.

: This is a retrospective study. For this type of study, formal consent is not required.

Document is current

Any future updates will be listed below